Arix Bioscience Plc Director/PDMR Shareholding (4854Y)

TIDMARIX

RNS Number : 4854Y

Arix Bioscience Plc

04 May 2023

Arix Bioscience plc

("Company")

PDMR notifications & Director Shareholdings

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

The Company has been notified that Robert Lyne, Chief executive Officer, has sold a total of 107,657 Ordinary shares of 0.001 pence each in the Company ("Shares") on 04 May 2023 at an average price of 105 pence per share and bought on 04 May 2023, into his ISAs and SIPP, a total of 107,657 Shares at an average price of 107 pence per share.

The notification below, made in accordance with the requirements of UK Market Abuse Regulation, provides further detail on the respective transactions.

 
       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                              Robert Lyne 
      --------------------------------  ----------------------------------------------------- 
       Reason for the notification 
  2 
      --------------------------------------------------------------------------------------- 
 a)    Position/status                   Chief Executive Officer 
      --------------------------------  ----------------------------------------------------- 
 b)    Initial notification              Initial Notification 
        /Amendment 
      --------------------------------  ----------------------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
      --------------------------------------------------------------------------------------- 
 a)    Name                              Arix Bioscience plc 
      --------------------------------  ----------------------------------------------------- 
 b)    LEI                               213800OVT3AHQCXNIX43 
      --------------------------------  ----------------------------------------------------- 
       Details of the transaction(s): section to be repeated for (i) 
  4     each type of instrument; (ii) each type of transaction; (iii) 
        each date; and (iv) each place where transactions have been conducted 
      --------------------------------------------------------------------------------------- 
 a)    Description of the                Arix Bioscience plc Ordinary shares of 0.001 
        financial instrument,             pence each 
        type of instrument 
       Identification code               GB00BD045071 
 b)    Nature of the transaction         Share Disposal 
----  --------------------------------  ----------------------------------------------------- 
c)     Price(s) and volume(s)                   Price(s)GBP                   Volume(s) 
      --------------------------------  -----  ----------------------------  ------------ 
                                                      1.) GBP1.052            22,238 
           2.) GBP1.053                                                        20,000 
           3.) GBP1.0526 
           4.) GBP1.0425                                                        8,419 
                                                                               57,000 
   ------------------------------------------------------------------------  ------------ 
 d)    Aggregated information 
  - Aggregated volume                107,657 
  - Price (GBP)                      GBP112,669.14 
 e)    Date of the transaction           4 May 2023 
 f)    Place of the transaction          London Stock Exchange 
      --------------------------------  ----------------------------------------------------- 
 
 
       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                                  Robert Lyne 
      ------------------------------------  ----------------------------------------------------- 
       Reason for the notification 
  2 
      ------------------------------------------------------------------------------------------- 
 a)    Position/status                       Chief Executive Officer 
      ------------------------------------  ----------------------------------------------------- 
 b)    Initial notification                  Initial Notification 
        /Amendment 
      ------------------------------------  ----------------------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------------------- 
 a)    Name                                  Arix Bioscience plc 
      ------------------------------------  ----------------------------------------------------- 
 b)    LEI                                   213800OVT3AHQCXNIX43 
      ------------------------------------  ----------------------------------------------------- 
       Details of the transaction(s): section to be repeated for (i) 
  4     each type of instrument; (ii) each type of transaction; (iii) 
        each date; and (iv) each place where transactions have been conducted 
      ------------------------------------------------------------------------------------------- 
 a)    Description of the                    Arix Bioscience plc Ordinary shares of 0.001 
        financial instrument,                 pence each 
        type of instrument 
       Identification code                   GB00BD045071 
 b)    Nature of the transaction             Share Purchase 
----  ------------------------------------  ----------------------------------------------------- 
c)     Price(s) and volume(s)                       Price(s)(GBP)             Volume(s) 
      ------------------------------------  -----  ------------------------  ---------------- 
                                                    GBP1.069                  57,014 
     GBP1.069                                                                  8,419 
     GBP1.068                                                                  42,224 
   ------------------------------------------------------------------------  ---------------- 
 d)    Aggregated information 
  - Aggregated volume                    107,657 
  - Price (GBP)                          GBP115,094.42 
 e)    Date of the transaction               4 May 2023 
 f)    Place of the transaction              London Stock Exchange 
      ------------------------------------  ----------------------------------------------------- 
 

Ends.

For further information please contact:

Kin Company Secretarial Limited, Company Secretary

[phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQZLFBXELBBBB

(END) Dow Jones Newswires

May 04, 2023 12:02 ET (16:02 GMT)